PLACEMENT AGENT PREFERRED INVESTMENT OPTION INMED PHARMACEUTICALS INC.Securities Agreement • June 30th, 2025 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 30th, 2025 Company Industry JurisdictionTHIS PLACEMENT AGENT PREFERRED INVESTMENT OPTION (the “Preferred Investment Option”) certifies that, for value received, [_____________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the eighteen (18) month anniversary of the Effective Date, provided that, if such date is not a Trading Day, the immediately following Trading Day (the “Termination Date”), but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to [______] shares (as subject to adjustment hereunder, the “Preferred Investment Option Shares”) of Common Shares. The purchase price of one share of Common Shares under this Preferred Investment Option shall be equal to the Exercise Price, as de
PREFERRED INVESTMENT OPTION INMED PHARMACEUTICALS INC.Securities Agreement • June 30th, 2025 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 30th, 2025 Company Industry JurisdictionTHIS PREFERRED INVESTMENT OPTION (the “Preferred Investment Option”) certifies that, for value received, [ ] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the eighteen (18) month anniversary of the Effective Date, provided that, if such date is not a Trading Day, the immediately following Trading Day (the “Termination Date”), but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to [ ] shares (as subject to adjustment hereunder, the “Preferred Investment Option Shares”) of Common Shares. The purchase price of one share of Common Shares under this Preferred Investment Option shall be equal to the Exercise Price, as defined in Section 2(b).